BioStock: Elicera Therapeutics partners with Baylor College of Medicine

Elicera Therapeutics has been gearing up for new clinical trials with its cancer cell and gene therapy projects. As part of that journey, the company has just announced a contract manufacturing collaboration with Baylor College of Medicine for the ELC-201 oncolytic virus project. BioStock reached out to Elicera’s co-founder Di Yu to learn more about the collaboration and its significance.

Read the interview with Di Yu at biostock.se:

https://www.biostock.se/en/2021/12/elicera-therapeutics-partners-with-baylor-college-of-medicine/

This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se